Kezar Life Sciences
59 hedge funds and large institutions have $31.6M invested in Kezar Life Sciences in 2024 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 14 increasing their positions, 22 reducing their positions, and 26 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
less funds holding
Funds holding: →
36% less repeat investments, than reductions
Existing positions increased: 14 | Existing positions reduced: 22
85% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 26
Holders
59
Holding in Top 10
1
Calls
$11K
Puts
–
Top Buyers
| 1 | +$2.81M | |
| 2 | +$580K | |
| 3 | +$401K | |
| 4 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
+$341K |
| 5 |
ACM
ADAR1 Capital Management
Austin,
Texas
|
+$195K |
Top Sellers
| 1 | -$14.3M | |
| 2 | -$558K | |
| 3 | -$379K | |
| 4 |
Northern Trust
Chicago,
Illinois
|
-$278K |
| 5 |
BNP Paribas Financial Markets
Paris,
France
|
-$266K |